This fact sheet provides information about using time temperature indicators to monitor heat exposure of oxytocin, a common drug used to prevent and treat postpartum hemorrhage.

Publication date: May 2014

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work to develop an oxytocin sublingual fast-dissolving tablet presentation that dissolves in less than ten seconds in the patient’s mouth without the need for additional water or diluent. Oxytocin in this type of presentation could potentially increase the reach and efficacy of this lifesaving medication to areas lacking access to skilled health workers, refrigeration, or safe injection equipment.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work in adapting the concept of a dilution bottle to simplify the process of magnesium sulfate administration for the treatment of preeclampsia and eclampsia. A dilution bottle bottle can facilitate the safe calculation of recommended doses by obviating the need to remember complex equations for dilution.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH’s work in collaboration with the University of Washington to develop a mobile application for magnesium sulfate administration for the treatment of preeclampsia and eclampsia. The application includes a dosing calculator and a detailed checklist based on World Health Organization protocol and is designed specifically to address the challenges of correctly calculating the dosage.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rectally administered magnesium sulfate (MgSO4) formulation that could simplify delivery and improve access to MgSO4 treatment in low-resource settings.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

Severe preeclampsia and eclampsia (PE/E) are among the leading causes of maternal death and disability worldwide. Magnesium sulfate is the treatment recommended by the World Health Organization, but it remains underutilized due to difficult administration. PATH designed a mobile application for dosing and dilution of magnesium sulfate to address the challenges of correctly calculating magnesium sulfate dosage given multiple concentrations and a complex dosing regimen.

Publication date: May 2014

Region: Global

This fact sheet highlights PATH's health technology solutions from the past 30 years.

Publication date: April 2014

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work on the Information Technology Initiative of the Joint Learning Network for Universal Health Coverage, an innovative learning community where practitioners and policymakers from around the globe co-develop knowledge that focuses on the practical “how to” of achieving universal health coverage. Find out more about PATH's work in digital health solutions.

Publication date: March 2014

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH's work on vaccine vial monitors.

Publication date: February 2014

Region: Global

Part of series: Technology Updates

This report outlines the key themes and recommendations identified during three policy dialogues hosted by PATH and partners in 2013 that highlight ways for public-private partnerships to effectively develop, adapt, and deliver lifesaving health innovations to those most in need.

Publication date: January 2014

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's Market Development Toolkit, which provides guidance and tools on the commercialization process for health products in low-resource settings.

Publication date: December 2013

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH’s work to advance an accurate, noninvasive device that could be used to screen for anemia in low-resource settings at the point of care by minimally trained health workers.

Publication date: November 2013

Region: Global

Part of series: Technology Updates

If a highly virulent pandemic strain were to emerge in today’s interconnected world, influenza has the potential to kill millions of people, especially in developing countries with limited to no resources for pandemic planning, preparedness, and outbreak response. PATH's work in developing thermostable influenza vaccines holds promise for extending product shelf life and easing logistics during introduction and rapid deployment to hard-to-reach populations—markedly improving developing-country preparedness and ability to contain the virus at its point of origin. This fact sheet describes our latest research achievements and next steps in product development.

Publication date: September 2013

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work to address the health effects of indoor air pollution for the more than one-third of the world's population that uses biomass to cook and heat their homes.

Publication date: August 2013

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes the Ultra Rice project at PATH.

Publication date: August 2013

Region: Global

Part of series: Technology Updates

This fact sheet from the Global Health Technologies Coalition outlines the FDA's role in global health and offers recommendations for how the FDA can continue to play an important role in efforts to ensure the safety of health tools to prevent, diagnose, and treat infectious diseases that affect millions of people worldwide every year.

Publication date: July 2013

Region: North America and Europe

Part of the Technology Updates series, this fact sheet describes PATH's work to identify and evaluate respiratory rate counters for the diagnosis of childhood pneumonia in low-resource settings. These include existing as well as innovative technologies in development.

Publication date: June 2013

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH’s work to develop a cell phone–based application to assist with management of childhood pneumonia in resource-limited settings. Called the mPneumonia application, it will incorporate a digital version of the Integrated Management of Childhood Illness algorithm with a software-based respiratory rate counter and a pulse oximeter, providing a user-friendly diagnostic and management tool.

Publication date: June 2013

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH’s work to evaluate existing package designs for amoxicillin dispersible tablets for the treatment of childhood pneumonia. The project will develop preliminary concepts for improved product design to facilitate distribution and clear instructions to facilitate treatment adherence.

Publication date: June 2013

Region: Global

Part of series: Technology Updates

This paper is the first in a series that will demonstrate how nonprofit product development organizations work to advance research and development for poverty-related and neglected diseases and conditions in low- and middle-income countries. This series is meant to inform global policy and financing debates, including but not limited to discussions on the recommendations outlined in the 2012 report from the WHO Consultative Expert Working Group on research and development.

Publication date: May 2013

Region: Global